Print this page
-
NCI/CTEP #10276: A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies.
Protocol: 052002Principal Investigator:
- Kristen Spencer DO, MPH (Rutgers University)
Applicable Disease Sites: Liver
Any Site
Other Digestive Organ -
AHEP1531: Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT) (Childrens Oncology Group).
Protocol: 111806Principal Investigator:
- Richard Drachtman M.D. (Rutgers University)
Applicable Disease Sites: Liver -
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Durvalumab Monotherapy or in Combination With Bevacizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma Who Are at High Risk of
Recurrence After Curative Hepatic Resection or Ablation (EMERALD-2).
Protocol: 071912Principal Investigator:
- Howard Hochster M.D (Rutgers University)
Applicable Disease Sites: Liver -
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma
Protocol: 001720Principal Investigator:
- Vinod Rustgi MD, MBA (Rutgers Robert Wood Johnson Medical School)
Applicable Disease Sites: Liver
